China: A new treatment approach for diabetic macular edema (DME), combining an initial intravitreal anti-vascular endothelial ...

For patients with diabetic macular edema (DME), intravitreal anti-vascular endothelial growth factor (anti-VEGF) injection followed by a dexamethasone (DEX) intravitreal implant demonstrates ...

Similar results in patients who had port delivery system for 4 years or switched after 64 ...

The first half of 2026 brought a steady drumbeat of regulatory and clinical news across the diabetic eye disease space, from ...

After a single intravitreal dose of 4D-150, visual acuity and anatomic control was maintained with consistent and durable treatment burden ...

Cascade Prodrug and Uneedle are partnering to test suprachoroidal delivery of CPD100 using Uneedle's Bella-Vue microneedle system for the treatment of wet AMD. Cascade Prodrug and Uneedle are ...

CG-P5, a topical peptide eye drop, met safety and efficacy endpoints for wet age-related macular degeneration, according to a ...

The market for treatments of macular degeneration, cited as the leading cause of blindness in the elderly, is growing rapidly. Macular degeneration is a condition where abnormal blood vessels grow ...

IRX-101 targets a significant need for millions of patients facing vision loss and has the potential to improve the standard ...

More than 60% of tarcocimab-treated patients had reduced severity ...

Trial met both co-primary endpoints of mean change from baseline in BCVA letter score and mean change from baseline CST with statistical ...